Jacob Newman Marcus

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. doi request reprint Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease
    Jacob Newman Marcus
    Department of Neurosymptomatics, Merck Research Laboratories, West Point, PA 19486, USA
    J Neurogenet 25:127-33. 2011

Detail Information

Publications1

  1. doi request reprint Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease
    Jacob Newman Marcus
    Department of Neurosymptomatics, Merck Research Laboratories, West Point, PA 19486, USA
    J Neurogenet 25:127-33. 2011
    ..This review will discuss several post-translational modifications of tau and their roles in modulation of tau function and aggregation in AD...